Ardelyx reported $381.87M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Amgen USD 34.96B 3.49B Jun/2026
Ardelyx USD 381.87M 447K Mar/2026
aTyr Pharma USD 67.58M 178.23M Mar/2026
Corcept Therapeutics USD 439.68M 13.64M Jun/2026
Curis USD 16.61M 9.7M Mar/2026
Sanofi EUR 30.16B 789M Mar/2026
TG Therapeutics USD 1.15B 58.72M Jun/2026
United Therapeutics USD 3.48B 611.7M Jun/2026